146 related articles for article (PubMed ID: 37795103)
21. MicroRNA-223 attenuates hepatocarcinogenesis by blocking hypoxia-driven angiogenesis and immunosuppression.
Fu Y; Mackowiak B; Feng D; Lu H; Guan Y; Lehner T; Pan H; Wang XW; He Y; Gao B
Gut; 2023 Oct; 72(10):1942-1958. PubMed ID: 36593103
[TBL] [Abstract][Full Text] [Related]
22. TOX promotes the exhaustion of antitumor CD8
Wang X; He Q; Shen H; Xia A; Tian W; Yu W; Sun B
J Hepatol; 2019 Oct; 71(4):731-741. PubMed ID: 31173813
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-195 vector influence on the development of gradually induced hepatocellular carcinoma in murine model.
El-Ahwany E; Mansy SS; Zoheiry M; Mourad L; Mahmoud S; Abu-Taleb H; Hassanien M; Hassan M
Ultrastruct Pathol; 2020 Mar; 44(2):203-210. PubMed ID: 32216509
[No Abstract] [Full Text] [Related]
24. Investigation of PD-1H in DEN-induced mouse liver cancer model.
Lei CJ; Wang B; Long ZX; Ren H; Pan QY; Li Y
Eur Rev Med Pharmacol Sci; 2018 Aug; 22(16):5194-5199. PubMed ID: 30178841
[TBL] [Abstract][Full Text] [Related]
25. Targeting Endoglin-Expressing Regulatory T Cells in the Tumor Microenvironment Enhances the Effect of PD1 Checkpoint Inhibitor Immunotherapy.
Schoonderwoerd MJA; Koops MFM; Angela RA; Koolmoes B; Toitou M; Paauwe M; Barnhoorn MC; Liu Y; Sier CFM; Hardwick JCH; Nixon AB; Theuer CP; Fransen MF; Hawinkels LJAC
Clin Cancer Res; 2020 Jul; 26(14):3831-3842. PubMed ID: 32332012
[TBL] [Abstract][Full Text] [Related]
26. Placental growth factor inhibition modulates the interplay between hypoxia and unfolded protein response in hepatocellular carcinoma.
Vandewynckel YP; Laukens D; Devisscher L; Bogaerts E; Paridaens A; Van den Bussche A; Raevens S; Verhelst X; Van Steenkiste C; Jonckx B; Libbrecht L; Geerts A; Carmeliet P; Van Vlierberghe H
BMC Cancer; 2016 Jan; 16():9. PubMed ID: 26753564
[TBL] [Abstract][Full Text] [Related]
27. Adaptive immunity suppresses formation and progression of diethylnitrosamine-induced liver cancer.
Schneider C; Teufel A; Yevsa T; Staib F; Hohmeyer A; Walenda G; Zimmermann HW; Vucur M; Huss S; Gassler N; Wasmuth HE; Lira SA; Zender L; Luedde T; Trautwein C; Tacke F
Gut; 2012 Dec; 61(12):1733-43. PubMed ID: 22267597
[TBL] [Abstract][Full Text] [Related]
28. Lenvatinib Plus Anti-PD-1 Combination Therapy for Advanced Cancers: Defining Mechanisms of Resistance in an Inducible Transgenic Model of Thyroid Cancer.
Bertol BC; Bales ES; Calhoun JD; Mayberry A; Ledezma ML; Sams SB; Orlicky DJ; Donadi EA; Haugen BR; French JD
Thyroid; 2022 Feb; 32(2):153-163. PubMed ID: 34641722
[No Abstract] [Full Text] [Related]
29. Serum exosomal miR-638 is a prognostic marker of HCC via downregulation of VE-cadherin and ZO-1 of endothelial cells.
Yokota Y; Noda T; Okumura Y; Kobayashi S; Iwagami Y; Yamada D; Tomimaru Y; Akita H; Gotoh K; Takeda Y; Tanemura M; Murakami T; Umeshita K; Doki Y; Eguchi H
Cancer Sci; 2021 Mar; 112(3):1275-1288. PubMed ID: 33426736
[TBL] [Abstract][Full Text] [Related]
30. Dissimilar patterns of promotion by di(2-ethylhexyl)phthalate and phenobarbital of hepatocellular neoplasia initiated by diethylnitrosamine in B6C3F1 mice.
Ward JM; Rice JM; Creasia D; Lynch P; Riggs C
Carcinogenesis; 1983 Aug; 4(8):1021-9. PubMed ID: 6872148
[TBL] [Abstract][Full Text] [Related]
31. iPLA2β-Null Mice Show HCC Protection by an Induction of Cell-Cycle Arrest after Diethylnitrosamine Treatment.
Andrade A; Poth T; Brobeil A; Merle U; Chamulitrat W
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430237
[TBL] [Abstract][Full Text] [Related]
32. Hypoxia mediates mutual repression between microRNA-27a and PPARγ in the pulmonary vasculature.
Kang BY; Park KK; Green DE; Bijli KM; Searles CD; Sutliff RL; Hart CM
PLoS One; 2013; 8(11):e79503. PubMed ID: 24244514
[TBL] [Abstract][Full Text] [Related]
33. Temporal advancement of diethylnitrosamine carcinogenesis in aging mice.
Clapp NK; Perkins EH; Klima WC; Cacheiro LH
J Gerontol; 1981 Mar; 36(2):158-63. PubMed ID: 7204896
[TBL] [Abstract][Full Text] [Related]
34. Macrophage GSK3β-deficiency inhibits the progression of hepatocellular carcinoma and enhances the sensitivity of anti-PD1 immunotherapy.
Sun G; Liu H; Zhao J; Zhang J; Huang T; Sun G; Zhao S; Zhang Z; Cao H; Rong D; Kong X; Ji Q; Liu L; Wang X; Tang W; Xia Y
J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36600662
[TBL] [Abstract][Full Text] [Related]
35. Cabozantinib Enhances Anti-PD1 Activity and Elicits a Neutrophil-Based Immune Response in Hepatocellular Carcinoma.
Esteban-Fabró R; Willoughby CE; Piqué-Gili M; Montironi C; Abril-Fornaguera J; Peix J; Torrens L; Mesropian A; Balaseviciute U; Miró-Mur F; Mazzaferro V; Pinyol R; Llovet JM
Clin Cancer Res; 2022 Jun; 28(11):2449-2460. PubMed ID: 35302601
[TBL] [Abstract][Full Text] [Related]
36. System analysis based on the cancer-immunity cycle identifies ZNF207 as a novel immunotherapy target for hepatocellular carcinoma.
Wang X; Zhou T; Chen X; Wang Y; Ding Y; Tu H; Gao S; Wang H; Tang X; Yang Y
J Immunother Cancer; 2022 Mar; 10(3):. PubMed ID: 35246476
[TBL] [Abstract][Full Text] [Related]
37. GLIS1 intervention enhances anti-PD1 therapy for hepatocellular carcinoma by targeting SGK1-STAT3-PD1 pathway.
Rong D; Wang Y; Liu L; Cao H; Huang T; Liu H; Hao X; Sun G; Sun G; Zheng Z; Kang J; Xia Y; Chen Z; Tang W; Wang X
J Immunother Cancer; 2023 Feb; 11(2):. PubMed ID: 36787938
[TBL] [Abstract][Full Text] [Related]
38. Safflower yellow reduces DEN-induced hepatocellular carcinoma by enhancing liver immune infiltration through promotion of collagen degradation and modulation of gut microbiota.
Fu H; Liu X; Jin L; Lang J; Hu Z; Mao W; Cheng C; Shou Q
Food Funct; 2021 Nov; 12(21):10632-10643. PubMed ID: 34585698
[TBL] [Abstract][Full Text] [Related]
39. Selective targeting of angiogenic tumor vasculature by vascular endothelial-cadherin antibody inhibits tumor growth without affecting vascular permeability.
Liao F; Doody JF; Overholser J; Finnerty B; Bassi R; Wu Y; Dejana E; Kussie P; Bohlen P; Hicklin DJ
Cancer Res; 2002 May; 62(9):2567-75. PubMed ID: 11980651
[TBL] [Abstract][Full Text] [Related]
40. Persistent mTORC1 activation via Depdc5 deletion results in spontaneous hepatocellular carcinoma but does not exacerbate carcinogen- and high-fat diet-induced hepatic carcinogenesis in mice.
Xu L; Yang C; Wang J; Li Z; Huang R; Ma H; Ma J; Wang Q; Xiong X
Biochem Biophys Res Commun; 2021 Nov; 578():142-149. PubMed ID: 34562654
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
